New vaccines against dengue fever and shingles licensed
VOV.VN - As many as 40 types of vaccines and biological products have been licensed by the Ministry of Health (MoH) to be put into circulation nationwide, including three new vaccines licensed for the first time.
They include Qdenga against dengue fever, Shingrix against shingles, and Shingrix Pneumovax 23 against 23 types of pneumococcal bacteria.
All three vaccines are produced by the world’s large pharmaceutical companies, namely Takeda of Japan, GSK of Belgium, and MSD of the United States.
According to Assoc. Prof. Dr. Tran Dac Phu, former Director of the Department of Preventive Medicine, the MoH has reviewed and evaluated the safety and effectiveness of the vaccines before being put into use in the nation.
Currently, the three vaccines are in the vaccination programme that requires payment.
